Trial
NCT02697253
Mechanisms Underlying Predictors of Success From Obesity Surgery
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition
Obesity
Intervention
Exendin 9-39 and Sitagliptin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-15